Journal
PITUITARY
Volume 16, Issue 1, Pages 46-55Publisher
SPRINGER
DOI: 10.1007/s11102-012-0428-2
Keywords
Mortality; Morbidity; Hypothalamic damage; Hypopituitarism; Cardiovascular risk; Quality of life; Cognitive function
Categories
Funding
- Swedish Research Council [K 2002-72X-14257-01]
- Swedish Children's Cancer Foundation
- Medical Faculty, Lund University, Sweden
Ask authors/readers for more resources
A craniopharyngioma (CP) is an embryonic malformation of the sellar and parasellar region. The annual incidence is 0.5-2.0 cases/million/year and approximately 60 % of CP are seen in adulthood. Craniopharyngiomas have the highest mortality of all pituitary tumors. Typical initial manifestations at diagnosis in adults are visual disturbances, hypopituitarism and symptoms of elevated intracranial pressure. The long-term morbidity is substantial with hypopituitarism, increased cardiovascular risk, hypothalamic damage, visual and neurological deficits, reduced bone health, and reduction in quality of life and cognitive function. Therapy of choice is surgery, followed by cranial radiotherapy in about half of the patients. The standardised overall mortality rate varies 2.88-9.28 in cohort studies. Patients with CP have a 3-19 fold higher cardiovascular mortality in comparison to the general population. Women with CP have an even higher risk.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available